Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

BACKGROUND: Patients with giant cell arteritis (GCA) treated with tocilizumab (TCZ) every week or every other week and prednisone tapering achieved superior rates of sustained remission to patients treated with placebo and prednisone tapering in a randomised controlled trial. Health-related quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Dimonaco, Sophie, Tuckwell, Katie, Klearman, Micki, Collinson, Neil, Stone, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381622/
https://www.ncbi.nlm.nih.gov/pubmed/30786937
http://dx.doi.org/10.1186/s13075-019-1837-7

Ejemplares similares

Ejemplares similares